Bruker (BRKR) free cash flow

Free cash flow · fiscal 2025
$13.90M

Bruker (BRKR) generated free cash flow of $13.90M in fiscal 2025 (the year ended December 31, 2025). That is 89.8% lower than the $136.00M of fiscal 2024. Figures as of 18 Nov 2026, 12:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$13.90M
Change on fiscal 2024
−89.8%
Growth, 5 years
−43.2% a year
Growth, 10 years
−23.2% a year
Highest on record
$243.20Mfiscal 2023
Lowest on record
$13.90Mfiscal 2025
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bruker free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow shrank at a compound 43.2% a year; over ten years the rate was −23.2% a year. Across the 17 fiscal years on record (2009–2025), the highest was $243.20M in fiscal 2023 and the lowest $13.90M in fiscal 2025.

History · 17 fiscal years

Free cash flow by fiscal year

Bruker free cash flow, year by year

Bruker (BRKR) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$13.90M 89.8% down
2024$136.00M 44.1% down
2023$243.20M 67.5% up
2022$145.20M 23.7% down
2021$190.40M 19.0% down
2020$235.00M 67.4% up
2019$140.40M 26.3% down
2018$190.50M 72.1% up
2017$110.70M 18.1% up
2016$93.70M 51.9% down
2015$195.00M 142.2% up
2014$80.50M 15.0% down
2013$94.70M 57.0% up
2012$60.30M 131.0% up
2011$26.10M 79.0% down
2010$124.20M 7.0% down
2009$133.50M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Bruker and comparable companies
CompanyFree cash flowFiscal year
Spyre Therapeutics SYRE-$169.25M2025
Qiagen QGEN$447.20M2025
Insulet PODD$349.90M2025
Bruker BRKR$13.90M2025
Globus Medical GMED$579.02M2025
Madrigal Pharmaceuticals MDGL-$193.02M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BRKR

Bruker, figure by figure

Bruker (BRKR) overview: price, valuation and scorecardAll health care companies by market value

Bruker free cash flow: questions and answers

What is Bruker's free cash flow?

Bruker (BRKR) generated free cash flow of $13.90M in fiscal 2025 (the year ended December 31, 2025). That is 89.8% lower than the $136.00M of fiscal 2024.

What is the growth rate of Bruker's free cash flow?

Over the five fiscal years to 2025 free cash flow shrank at a compound 43.2% a year; over ten years the rate was −23.2% a year.

What are the highest and lowest free cash flow figures on record for Bruker?

Across the 17 fiscal years on record (2009–2025), the highest was $243.20M in fiscal 2023 and the lowest $13.90M in fiscal 2025.

How is Bruker's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Bruker it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bruker (BRKR) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/BRKR/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.